tiprankstipranks
Trending News
More News >
Jamieson Wellness Inc (TSE:JWEL)
TSX:JWEL
Advertisement

Jamieson Wellness Inc (JWEL) AI Stock Analysis

Compare
207 Followers

Top Page

TSE:JWEL

Jamieson Wellness Inc

(TSX:JWEL)

Select Model
Select Model
Select Model
Neutral 68 (OpenAI - 4o)
Rating:68Neutral
Price Target:
C$39.00
▲(10.17% Upside)
Jamieson Wellness Inc's strong financial performance is the primary driver of its stock score, supported by consistent revenue growth and profitability. Technical indicators suggest the stock is nearing oversold territory, offering potential upside. Valuation metrics are moderate, with a reasonable dividend yield enhancing its appeal.
Positive Factors
Revenue Growth
Consistent revenue growth indicates a strong market position and effective business strategies, supporting long-term financial stability.
Cash Flow Management
Effective cash flow management enhances financial flexibility, allowing the company to invest in growth opportunities and manage liabilities efficiently.
Profit Margins
Strong profit margins reflect efficient operations and pricing power, contributing to sustainable profitability and competitive advantage.
Negative Factors
EBIT Margin Decline
A decline in EBIT margin can indicate rising costs or pricing pressures, which may affect future profitability if not managed effectively.
Cash Flow Coverage
Suboptimal cash flow coverage can limit the company's ability to meet short-term obligations and invest in growth, impacting financial resilience.
Leverage Position
While leverage is balanced, any increase in debt levels could strain financial resources, affecting long-term financial health and flexibility.

Jamieson Wellness Inc (JWEL) vs. iShares MSCI Canada ETF (EWC)

Jamieson Wellness Inc Business Overview & Revenue Model

Company DescriptionJamieson Wellness Inc., together with its subsidiaries, develops, manufactures, distributes, markets, and sells natural health products in Canada and internationally. The company operates in two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment offers health products for humans, including vitamins, herbals, and mineral nutritional supplements; and over-the-counter remedies under the Jamieson and Lorna Vanderhaeghe brands, as well as sports nutrition products under the Progressive, Precision, and Iron Vegan brands. The Strategic Partners segment provides manufacturing and product development services on a contract manufacturing basis to blue-chip consumer health companies and retailers. Jamieson Wellness Inc. sells its products to distributors, and retail and wholesale customers. The company was formerly known as Jamieson Intermediate Holdings Ltd. and changed its name to Jamieson Wellness Inc. in May 2017. Jamieson Wellness Inc. was founded in 1922 and is headquartered in Toronto, Canada.
How the Company Makes MoneyJamieson Wellness Inc makes money primarily through the sale of its vitamins, minerals, and supplements (VMS) products. Its revenue model is based on a combination of direct sales through retail partners and online platforms, as well as distribution agreements with key retailers and pharmacies. The company has a diversified portfolio of brands, including its flagship Jamieson brand, which contributes significantly to its revenue stream. Additionally, Jamieson Wellness engages in strategic partnerships and acquisitions to expand its product offerings and market reach. Factors such as product innovation, brand recognition, and a strong distribution network also play crucial roles in driving the company's earnings.

Jamieson Wellness Inc Earnings Call Summary

Earnings Call Date:Aug 07, 2025
(Q3-2024)
|
% Change Since: |
Next Earnings Date:Oct 30, 2025
Earnings Call Sentiment Positive
The earnings call presented a strong performance for Jamieson Wellness with significant revenue growth, especially in China and international markets. Despite some challenges in the Strategic Partners segment and increased expenses, the overall trajectory remains positive with strong cash flow and dividend payouts.
Q3-2024 Updates
Positive Updates
Record Revenue Growth
Consolidated revenue reached $176 million, a 16% increase compared to the prior year, with branded revenue growth of 20%.
Strong Performance in China
China revenue increased almost 82% in Q3 and 89% year-to-date, driven by marketing and promotional investments.
International Expansion Success
International revenue increased by 25% in Q3 and 17% year-to-date with growth in every operating region.
Improved Gross Margins
Consolidated gross profit margin increased by 460 basis points to 38.4%, driven by higher branded sales.
Positive Cash Flow and Dividend Announcement
Generated cash from operations before working capital of $18.5 million, with a declared dividend of $0.21 per common share.
Negative Updates
Decline in Strategic Partners Segment
Revenue in the Strategic Partners segment was down by 5% due to the closeout of a previous customer contract.
Increased SG&A Expenses
SG&A expenses grew by 36.4% to $42 million, primarily due to marketing investments and IT system implementation costs.
Lower Margins in Strategic Partners
Gross profit margin in Strategic Partners decreased by 460 basis points to 10.9% due to lower volumes and customer mix.
Company Guidance
During the Jamieson Wellness earnings call for Q3 2024, the company provided detailed guidance for the fiscal year. Consolidated revenue for the year is expected to range between $725 million and $755 million, reflecting an increase of 7.2% to 11.7%. The Jamieson Brands segment is projected to see revenue between $620 million and $645 million, marking a growth of 12.5% to 17%. Meanwhile, Strategic Partner revenue is anticipated to decrease by 12% to 16%, with expectations set between $105 million and $110 million. The company also narrowed its guidance for consolidated adjusted EBITDA to between $139 million and $143 million, representing up to 3.6% growth. Adjusted diluted earnings per share are projected to reach $1.57 to $1.63, indicating growth of up to 5.2% compared to the previous year.

Jamieson Wellness Inc Financial Statement Overview

Summary
Jamieson Wellness Inc exhibits strong financial health with consistent revenue growth and profitability. The company maintains a balanced leverage position and effective cash flow management. Minor areas for improvement include EBIT margin stabilization and cash flow coverage.
Income Statement
85
Very Positive
Jamieson Wellness Inc has demonstrated consistent revenue growth, with a TTM (Trailing-Twelve-Months) revenue increase of 1.9%. The company maintains healthy gross and net profit margins, with the TTM gross profit margin at 38.3% and net profit margin at 7.1%. EBIT and EBITDA margins are stable, indicating efficient operations. However, the slight decline in EBIT margin from the previous year suggests potential cost pressures.
Balance Sheet
75
Positive
The company's balance sheet shows a moderate debt-to-equity ratio of 0.61, indicating a balanced approach to leveraging. Return on Equity (ROE) is solid at 11.4%, reflecting effective use of equity to generate profits. However, the equity ratio is not explicitly provided, which limits a full assessment of asset financing stability.
Cash Flow
80
Positive
Jamieson Wellness Inc has shown strong free cash flow growth of 4.15% in the TTM period. The operating cash flow to net income ratio of 0.78 and free cash flow to net income ratio of 0.89 indicate good cash conversion efficiency. The company has improved its cash flow metrics over time, though the operating cash flow coverage ratio suggests room for improvement in cash flow management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue766.01M733.78M676.17M547.37M451.03M403.66M
Gross Profit303.83M275.61M233.56M198.34M162.44M144.76M
EBITDA121.92M114.60M108.78M100.17M90.40M75.30M
Net Income58.00M51.91M47.88M52.81M52.08M41.60M
Balance Sheet
Total Assets1.17B1.21B1.14B1.11B652.48M609.34M
Cash, Cash Equivalents and Short-Term Investments50.54M44.79M36.86M26.24M6.78M1.17M
Total Debt417.65M308.29M462.99M400.00M149.13M149.06M
Total Liabilities658.93M660.41M662.38M675.67M310.45M316.94M
Stockholders Equity468.37M505.18M438.93M431.59M342.02M292.40M
Cash Flow
Free Cash Flow93.42M51.41M22.41M36.02M22.12M27.43M
Operating Cash Flow104.97M61.58M31.71M50.59M44.41M40.60M
Investing Cash Flow-20.24M-10.16M-35.13M-256.53M-22.28M-13.17M
Financing Cash Flow-56.68M-45.43M14.04M225.41M-16.51M-26.46M

Jamieson Wellness Inc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price35.40
Price Trends
50DMA
36.01
Negative
100DMA
35.44
Negative
200DMA
33.70
Positive
Market Momentum
MACD
0.07
Positive
RSI
35.09
Neutral
STOCH
13.17
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:JWEL, the sentiment is Negative. The current price of 35.4 is below the 20-day moving average (MA) of 37.11, below the 50-day MA of 36.01, and above the 200-day MA of 33.70, indicating a neutral trend. The MACD of 0.07 indicates Positive momentum. The RSI at 35.09 is Neutral, neither overbought nor oversold. The STOCH value of 13.17 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:JWEL.

Jamieson Wellness Inc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
68
Neutral
C$1.54B26.5612.75%2.43%11.87%56.93%
46
Neutral
7.48M-0.38-865.07%-22.92%39.22%
37
Underperform
19.62M-10.2964.79%72.95%
33
Underperform
1.41M-0.20-86.17%
27
Underperform
6.06M-3.17-96.63%32.78%
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
TSE:JWEL
Jamieson Wellness Inc
35.40
1.81
5.39%
DTEAF
DAVIDsTEA
0.57
0.32
128.00%
BABYF
Else Nutrition Holdings Inc
0.01
-0.01
-50.00%
NPRFF
Nepra Foods
0.12
0.04
50.00%
TSE:CULT
Cult Food Science Corp.
0.02
-0.04
-66.67%
TSE:PNGA
Pangea Natural Food, Inc.
0.40
0.19
90.48%

Jamieson Wellness Inc Corporate Events

DividendsBusiness Operations and StrategyFinancial Disclosures
Jamieson Wellness Inc. Reports Strong Q2 2025 Results with Significant Growth in China
Positive
Aug 7, 2025

Jamieson Wellness Inc. reported strong second quarter results for 2025, with a 13.8% increase in branded revenue, driven by successful marketing and promotional strategies across key markets. The company’s growth was highlighted by a 73% increase in its Chinese market due to the effective 6/18 program, alongside notable gains in Canada and the U.S. The results reflect Jamieson’s strategic execution and innovation in product offerings, which have bolstered its market position and operational performance, leading to increased dividends and a focus on global expansion.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Financial Disclosures
Jamieson Wellness to Announce Q2 2025 Financial Results
Neutral
Jul 24, 2025

Jamieson Wellness Inc. announced it will release its second quarter 2025 financial results on August 7, 2025, followed by a conference call for investors. This announcement is significant as it provides stakeholders an opportunity to gain insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and investor relations.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Shareholder Meetings
Jamieson Wellness Inc. Reports Successful Election of Directors at 2025 Shareholder Meeting
Positive
May 27, 2025

Jamieson Wellness Inc. announced the successful election of its nominee directors at the 2025 Annual Meeting of Shareholders, with all directors receiving overwhelming support. This development underscores the company’s stable governance and continued focus on expanding its market presence in the natural health industry.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Private Placements and FinancingBusiness Operations and Strategy
Jamieson Wellness Redeems Series A Preference Shares, Strengthens China Market Position
Positive
May 23, 2025

Jamieson Wellness Inc. announced the redemption of its Series A Preference Shares held by DCP Capital Partners, reflecting a strategic financial move aligned with DCP’s investment cycle. This redemption underscores the successful partnership between Jamieson and DCP, which has significantly bolstered Jamieson’s presence in China’s VMS market, contributing to substantial growth and positioning the company for continued success in this critical market.

The most recent analyst rating on (TSE:JWEL) stock is a Buy with a C$42.00 price target. To see the full list of analyst forecasts on Jamieson Wellness Inc stock, see the TSE:JWEL Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Sep 27, 2025